Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the α7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia:: Synthesis and structure-activity relationship

被引:178
作者
Wishka, Donn G. [1 ]
Walker, Daniel P. [1 ]
Yates, Karen M. [1 ]
Reitz, Steven C. [1 ]
Jia, Shaojuan [1 ]
Myers, Jason K. [1 ]
Olson, Kirk L. [1 ]
Jacobsen, E. Jon [1 ]
Wolfe, Mark L. [1 ]
Groppi, Vincent E. [1 ]
Hanchar, Alexander J. [1 ]
Thornburgh, Bruce A. [1 ]
Cortes-Burgos, Luz A. [1 ]
Wong, Erik H. F. [1 ]
Staton, Brian A. [1 ]
Raub, Thomas J. [1 ]
Higdon, Nicole R. [1 ]
Wall, Theron M. [1 ]
Hurst, Raymond S. [1 ]
Walters, Rodney R. [1 ]
Hoffmann, William E. [1 ]
Hajos, Mihaly [1 ]
Franklin, Stanley [1 ]
Carey, Galen [1 ]
Gold, Lisa H. [1 ]
Cook, Karen K. [1 ]
Sands, Steven B. [1 ]
Zhao, Sabrina X. [1 ]
Soglia, John R. [1 ]
Kalgutkar, Amit S. [1 ]
Arneric, Stephen P. [1 ]
Rogers, Bruce N. [1 ]
机构
[1] Pfizer Global Res & Dev, Groton, CT 06340 USA
关键词
D O I
10.1021/jm0602413
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
N-[(3R)-1-Azabicyclo[2.2.2] oct-3-yl] furo[2,3-c]pyridine-5-carboxamide (14, PHA-543,613), a novel agonist of the alpha 7 neuronal nicotinic acetylcholine receptor (alpha 7 nAChR), has been identified as a potential treatment of cognitive deficits in schizophrenia. Compound 14 is a potent and selective alpha 7 nAChR agonist with an excellent in vitro profile. The compound is characterized by rapid brain penetration and high oral bioavailability in rat and demonstrates in vivo efficacy in auditory sensory gating and, in an in vivo model to assess cognitive performance, novel object recognition.
引用
收藏
页码:4425 / 4436
页数:12
相关论文
共 65 条
[51]  
Schmitt JD, 2000, CURR MED CHEM, V7, P749
[52]  
SEGUELA P, 1993, J NEUROSCI, V13, P596
[53]   Furopyridines .21. Synthesis of cyano derivatives of furo[2,3-b]-, -[2,3-c]- and -[3,2-c]pyridine and their conversion to derivatives having another carbon-substituent [J].
Shiotani, S ;
Taniguchi, K .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1997, 34 (02) :493-499
[54]   Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia [J].
Sirota, P ;
Mosheva, T ;
Shabtay, H ;
Giladi, N ;
Korczyn, AD .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (02) :287-289
[55]   The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent [J].
Soglia, JR ;
Harriman, SP ;
Zhao, S ;
Barberia, J ;
Cole, MJ ;
Boyd, JG ;
Contillo, LG .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 36 (01) :105-116
[56]   Selective α7 nicotinic receptor stimulation normalizes chronic cocaine-induced loss of hippocampal sensory inhibition in C3H mice [J].
Stevens, KE ;
Kem, WR ;
Freedman, R .
BIOLOGICAL PSYCHIATRY, 1999, 46 (10) :1443-1450
[57]   Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice [J].
Stevens, KE ;
Kem, WR ;
Mahnir, VM ;
Freedman, R .
PSYCHOPHARMACOLOGY, 1998, 136 (04) :320-327
[58]   RAPID CHROMATOGRAPHIC TECHNIQUE FOR PREPARATIVE SEPARATIONS WITH MODERATE RESOLUTION [J].
STILL, WC ;
KAHN, M ;
MITRA, A .
JOURNAL OF ORGANIC CHEMISTRY, 1978, 43 (14) :2923-2925
[59]   PARAVENTRICULAR NUCLEUS - A SITE FOR THE INTEGRATION OF NEUROENDOCRINE AND AUTONOMIC MECHANISMS [J].
SWANSON, LW ;
SAWCHENKO, PE .
NEUROENDOCRINOLOGY, 1980, 31 (06) :410-417
[60]   (+)-3-[2-(benzo[b]thiophen-2-yl)-2-oxoethyl]-1-azabicyclo[2.2.2]octane, as potent agonists for the α7 nicotinic acetylcholine receptor [J].
Tatsumi, R ;
Seio, K ;
Fujio, M ;
Katayama, J ;
Horikawa, T ;
Hashimoto, K ;
Tanaka, H .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (14) :3781-3784